Log in to save to my catalogue

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controll...

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controll...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1691595087

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial

About this item

Full title

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Intensive care medicine, 2015-07, Vol.41 (7), p.1197-1208

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Importance
Acute kidney injury (AKI) is characterized by severe loss of glomerular filtration rate (GFR) and is associated with a prolonged intensive care unit (ICU) stay and increased risk of death. No interventions have yet been shown to prevent AKI or preserve GFR in critically ill patients. Evidence from mammalian physiology and small clinic...

Alternative Titles

Full title

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1691595087

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1691595087

Other Identifiers

ISSN

0342-4642

E-ISSN

1432-1238

DOI

10.1007/s00134-015-3827-9

How to access this item